Air-polishing With Erythritol During Orthodontic Tretament
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-16
SponsorCatherine Giannopoulou
About this trial
Patients with multi-bracketed fixed orthodontic treatment are at increased risk of developing white spot lesions (WSL) and gingivitis. Various preventive strategies have been examined to prevent the development of WSLs. During initial non-surgical periodontal therapy, the use of subgingival air-polishing with erythritol powder has shown promising results in reducing deep pockets and gingival inflammation. The efficacy of its use as monotherapy in preventing WSLs and gingival inflammation in patients during orthodontic treatment, has not yet been tested.
The primary objective of the present study is to compare the effectiveness of an air-polishing device used as monotherapy versus ultrasonic instrumentation (the current gold standard procedure) in preventing white spot lesions (WSL) and gingivitis among young patients undergoing multi-bracketed fixed orthodontic treatment.
Eligibility criteria
Qualifiers
Subjects about to undergo fixed orthodontic treatment will be invited to participate.
Age between 12 and 16 years only participants
Informed written consent obtained by the parents
Disqualifiers
Clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.),
Known or suspected non-compliance, drug or alcohol abuse
Inability to follow the procedures of the investigation, e.g. due to language problems, psychological disorders, dementia, etc. of the subject
Participation in another investigation with an investigational drug or another MD within the 30 days preceding and during the present investigation
Trial design
Treatments tested in this trial
- Ultrasonic scaler
- Air-Flow Prophylaxis Master
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Catherine Giannopoulou
Lead sponsor
University of Geneva, Switzerland
Sponsor institution
University of Geneva, Switzerland
Collaborator
Source ClinicalTrials.gov